US pharma major Pfizer has terminated its $160 billion-worth deal to acquire Ireland-based drug firm Allergan, following changes introduced by the US Treasury Department, Pfizer announced on Wednesday. Pfizer will pay $150 million to Allergan in reimbursement for expenses associated with the transaction. The deal announced last year would have been the largest ever healthcare acquisition. 